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Primordial germ cells (PGCs) undergo dramatic rear-
rangements to their methylome during embryo-
genesis, including initial genome-wide DNA deme-
thylation that establishes the germline epigenetic
ground state. The role of the 5-methylcytosine
(5mC) dioxygenases Tet1 and Tet2 in the initial
genome-wide DNA demethylation process has not
been examined directly. Using PGCs differentiated
from either control or Tet2/; Tet1 knockdown
embryonic stem cells (ESCs), we show that in vitro
PGC (iPGC) formation and genome-wide DNA deme-
thylation are unaffected by the absence of Tet1 and
Tet2, and thus 5-hydroxymethylcytosine (5hmC).
However, numerous promoters and gene bodies
were hypermethylated in mutant iPGCs, which is
consistent with a role for 5hmC as an intermediate
in locus-specific demethylation. Altogether, our re-
sults support a revised model of PGC DNA demethy-
lation in which the first phase of comprehensive 5mC
loss does not involve 5hmC. Instead, Tet1 and Tet2
have a locus-specific role in shaping the PGC epige-
nome during subsequent development.
INTRODUCTION
DNA methylation is an epigenetic mark involving the addition of
a methyl group to the fifth carbon of a cytosine base (5mC). In
mammalian cells, DNA methylation is established and main-
tained mostly in CG sequence contexts, and the amount of cyto-
sine methylation in a given genome is relatively stable (Feng
et al., 2010). Despite this stability, there are periods in embryonic
development where DNA methylation is significantly reduced,
including after oocyte fertilization, during preimplantation
embryo development, and during primordial germ cell (PGC)470 Cell Stem Cell 12, 470–478, April 4, 2013 ª2013 Elsevier Inc.formation (Gkountela et al., 2012; Guibert et al., 2012; Hackett
et al., 2013; Hajkova et al., 2008; Hajkova et al., 2002; Hajkova
et al., 2010; Monk et al., 1987; Okano et al., 1999; Popp et al.,
2010; Seisenberger et al., 2012; Seki et al., 2005; Smith et al.,
2012). Recent work has revealed a critical role for the oxidation
of 5mC to 5-hydroxymethylcytosine (5hmC) by Tet methylcyto-
sine dioxygenase 1 (Tet1) and Tet2 in locus-specific DNA deme-
thylation in PGCs (Yamaguchi et al., 2012; Hackett et al., 2013).
However, a role for 5hmC in the initial widespread (global) deple-
tion of DNA demethylation in PGCs has not been addressed
(Figure 1A).
PGCs are the founder cells of the metazoan germline, and
abnormal PGC development causes infertility or cancer.
Mammalian PGCs are specified de novo in each generation
from the epiblast (Lawson and Hage, 1994; Ohinata et al.,
2006; Tam and Zhou, 1996; Ying et al., 2001) and begin as highly
methylated cells (Seki et al., 2005). Although methylation is
critical for lineage specialization (Lei et al., 1996), it poses an
inherent problem for PGCs, which become globally depleted of
DNA methylation by e13.5 (Guibert et al., 2012; Kafri et al.,
1992; Monk et al., 1987; Popp et al., 2010). This differential has
lead to a longstanding hypothesis that a loss of methylation in
PGCs prior to e13.5 is necessary to restore the germline epige-
netic ground state, but the mechanisms for this restoration are
not well understood (Reik and Walter, 2001).
PGCs undergo DNA demethylation in two phases (Seisen-
berger et al., 2012) (Figure 1A). The first phase involves global
depletion of cytosine methylation with the retention of locus-
specific methylation at imprinting control centers (ICCs), single
copy genes, and repetitive elements (Guibert et al., 2012;
Hackett et al., 2013; Hajkova et al., 2002; Lane et al., 2003;
Lees-Murdock et al., 2003; Seki et al., 2005). The second phase
occurs from e9.5 to e13.5, where methylation is depleted from
the PGC genome in a locus-specific manner (Guibert et al.,
2012; Hackett et al., 2013; Hajkova et al., 2008; Hajkova et al.,
2002; Hajkova et al., 2010; Popp et al., 2010; Seisenberger
et al., 2012; Yamaguchi et al., 2012). Recent work has revealed
a role for Tet1 in the locus-specific demethylation of meiotic
genes (Yamaguchi et al., 2012). However, given that 5hmC levels
Figure 1. Generation of PGCs from ESCs Results in a Significant Decrease in CG Methylation
(A) A two-phase model of PGC demethylation is shown. PGCs are specified from pluripotent cells (yellow) and initially contain high levels of 5mC (black nucleus).
In phase 1, PGCs younger than e9.5 (blue) undergo global DNA demethylation (Seisenberger et al., 2012). In phase 2, PGCs undergo locus-specific demethylation
(white nucleus). Tet1 and Tet2 regulate locus-specific demethylation in phase 2 (Hackett et al., 2013). The role of Tet1 and Tet2 in global demethylation is
unknown.
(B) Single cell analysis of sorted iPGCs.
(C) Quantification of cytosine methylation in the CG sequence context by BS-seq. Shown is mean ± SD (n = 3).
(D) Metaplot analysis of CG methylation at NCBI Reference Sequence (RefSeq) genes.
(E) Pearson analysis of differentially methylated sites (DMS) with gene expression.
(F) Metaplot of CG methylation at CG islands (CGIs).
(G) Gene ontology analysis of 100 CGIs with significantly higher methylation levels in iPGCs.
(H) Bisulfite PCR of Tex12 CGI. Black circles, methylated cytosines; white circles, unmethylated cytosines.
(I) Distribution of cytosine methylation in ESCs and iPGCs. Binned bars representing 10% increments of methylation are graphed along the x axis.
(J) Frequency of methylation symmetry in CG sequence contexts in iPGCs after differentiation from ESCs. *, p < 0.05.
See also Figure S1 and Tables S1 and S2.
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Tet1 and Tet2 DNA Demethylation of PGCswere reduced by only 45% in this model, it is conceivable that
a second Tet protein may have compensated for loss of Tet1.
More recently, a double knockdown of Tet1 and Tet2 in embry-
onic stem cell (ESC)-derived PGCs revealed a role for Tet1 and
Tet2 in the demethylation of germline genes Deleted in
azoospermia-like (Dazl), Maelstrom (Mael), and Synaptonemal
complex protein 3 (Sycp3) (Hackett et al., 2013). However, it
was not determined whether Tet1 and Tet2 act to regulate global
DNA demethylation in phase 1.
In the current study, our goal was to evaluate the role of Tet1
and Tet2 in genome-wide DNA demethylation by differentiating
in vitro PGCs (iPGCs) from ESCs. It has previously been
reported that this method robustly captures immature PGCs
transcriptionally younger than e10.5 of development at high
purity (Vincent et al., 2011). However, it is not known whether
global DNA demethylation occurs in this model. Therefore, this
study had two goals. The first goal was to examine whether
the differentiation of iPGCs from ESCs involves a genome-
wide depletion of DNA methylation from the iPGC genome
and, if so, the second goal was to use this model to determine
whether Tet1 and Tet2 regulate phase 1 genome-wide demethy-
lation in PGCs.
RESULTS
PGCs undergo DNA demethylation in two phases (Seisenberger
et al., 2012). In phase 1, 5mC is depleted globally from the
genome with rare, locus-specific retention of methylation,
including the ICC of Snrpn (Figures S1A–S1D available online).
To determine whether ESC-derived iPGCs undergo genome-
wide demethylation, we used two independently derived ESC
lines (V6.5 and Rosa26-GFP) and differentiated iPGCs with
embryoid body (EB) differentiation. The iPGCs were sorted on
day 6 with surface markers stage-specific embryonic antigen 1
(SSEA1) and c-kit and then gated on the SSEA1+ and c-kitbright
double positive population (Figure S1F). The transcriptional iden-
tity of iPGCs was confirmed with single-cell gene expression
analysis of 40 SSEA1+c-kitbright cells from the XY V6.5 back-
ground (Figure 1B). In this study, a higher cross threshold (Ct)
indicated lower gene expression, and black indicated no detect-
able Ct and therefore no expression. We found that 38 of 40
iPGCs coexpressed the PGC genes Blimp1 and Dppa3 and
that single iPGCsheterogeneously expressedDeadendhomolog
1 (Dnd1), as previously reported (Vincent et al., 2011). We also
determined that the XY iPGCsdonot express the spermatogonial
marker Plzf and are negative for somatic lineage markers
Hoxa1 and Hoxb1. Using bisulfite (BS) treatment of iPGC DNA
followed by PCR amplification of the Snprn ICC, we demonstrate
that iPGCs on day 6 are methylated, indicating that iPGCs
have not completed phase 2 demethylation (Figure S1E).
Next, we performed whole-genome BS sequencing (BS-seq)
to compare cytosine methylation in ESCs and iPGCs (Table
S1). Notably, BS treatment does not distinguish between 5mC
and 5hmC (Huang et al., 2010). Therefore, the use of BS was
for detecting the sum of 5mC and 5hmC. Cytosine methylation
was mapped with the use of BS Seeker (Chen et al., 2010) with
mouse genome build mm9 (UCSC Genome Browser) allowing
up to three mismatches. Using this approach, we quantified
a statistically significant (p < 0.05) reduction in the levels of CG472 Cell Stem Cell 12, 470–478, April 4, 2013 ª2013 Elsevier Inc.methylation in iPGCs relative to ESCs (Figure 1C). Specifically,
we determined that, on average, 75% of cytosines in a CG
sequence context in ESCs were methylated, whereas, in iPGCs,
this was reduced to 47%. Cytosine methylation was also
observed in non-CG contexts. However, the amounts of non-
CG methylation were low, at around 2% or less (Table S1).
Though non-CGmethylation in iPGCs trended toward depletion,
this trend did not reach statistical significance.
To map genomic regions where a loss of CG methylation
occurred, we sequenced undifferentiated ESCs to 6.83 and
iPGCs to 6.93 coverage per strand, resulting in 478,482,437
cytosines coveredR 43 in both samples. Sites with delta meth-
ylation levels R 30% were subject to two-way binomial tests,
which yielded 11,994,107 CG sites for further analysis. We deter-
mined that 8,623,115 methylated cytosines in a CG sequence
context were significantly decreased in iPGCs, whereas only
81,884 methylated cytosines in a CG sequence context were
significantly increased in iPGCs relative to ESCs (FDR % 5%).
Chromosomal views of iPGCs in 1 million bp windows revealed
a chromosome-wide depletion of CG methylation across all
chromosomes (Figure S1G). Metaplots of reference genes
showed typical depletion of CG methylation at the transcription
start site (TSS) in both iPGCs and ESCs but general hypomethy-
lation in iPGCs across all upstream and downstream regions
(Figure 1D). Examination of repeat regions including nuclear
elements (SINEs and LINEs) revealed a similar depletion in CG
methylation (Figures S1H and S1I). Next, we used a Shannon
entropy calculation to capture the heterogeneity of methylated
cytosines between samples (Figure S1J). We found that the
entropy was considerably higher in iPGCs in comparison to
ESCs. This was true for genes, pseudogenes, exons, and
introns. The one exception was gene promoters (defined as
800 bp to +200 bp of the TSS), where the entropy was almost
equivalent between ESCs and iPGCs. Altogether, we conclude
that the loss of cytosine methylation from iPGCs occurred
genome-wide and that the increased entropy indicates that the
iPGC population is heterogeneously (not synchronously) under-
going demethylation.
To determine whether global changes in cytosine methylation
correlate with global changes in gene expression, we plotted
differentially methylated CG sites (DMS) against the average
change in gene expression between ESCs and iPGCs for each
reference gene (Figure 1E). ESC and iPGC gene expression
data were obtained from Vincent et al., 2011. A Pearson correla-
tion coefficient for all comparisons revealed that the DMS at
promoters, gene bodies, exons, and introns exhibited no corre-
lation to either an increase or a decrease in gene expression in
iPGCs relative to ESCs (Figures 1E and S1K). Unlike the majority
of the PGC genome, analysis of CG islands (CGIs) revealed no
change in the percentage of CG methylation (Figure 1F).
However, a small number of promoter CGIs significantly gained
methylation in iPGCs, and these were enriched in gene ontology
groups associated with meiosis (Figure 1G and Table S2). This
was confirmed by bisulfite PCR of the meiotic gene Tex12 CGI
(Figure 1H). Altogether, these data demonstrate that methylation
at CGIs undergoes dynamic and unique reorganization with
iPGC differentiation.
Next, we evaluated changes in the distribution of methylated
CGs in ESCs and iPGCs by mapping methylation levels
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ure 1I). Cytosine methylation in ESCs exhibited a typical bimodal
distribution where 59.6% of cytosines had R80% methylation
(red, high), whereas 12.2% of cytosines had% 20%methylation
(blue, low). In contrast, in iPGCs, we observed a substantial
loss of cytosine methylation from the high category and a near
doubling of cytosines in the low category (from 12.2% to
21.6%). The largest change between ESCs and iPGCs was in
their progression to the intermediate category (yellow, > 0.2
and < 0.8), where methylation more than doubled (from 28.2%
to 65.3%).
Finally, we evaluated the symmetry of cytosine methylation
(Figure 1J). In this analysis, mC+mG refers to symmetrically
methylated CG sites where the cytosine from both strands of
DNA (with the opposite strand read as G) are methylated. Simi-
larly, a symmetrically unmethylated site is represented by
uC+uG. Our analysis shows that, when iPGCs are differentiated
from ESCs, there is a loss in symmetrical methylation and a
3-fold increase in asymmetrical methylation (Figure 1J). Alto-
gether, the differentiation of iPGCs from ESCs results in a
genome-wide reduction in cytosine methylation similar to what
was previously reported for immature PGCs in phase 1 (Seisen-
berger et al., 2012).
Tet Proteins and 5hmC Are Found in PGCs In Vivo
and In Vitro
Given the role for Tet-mediated conversion of 5mC to 5hmC as
an intermediate in locus-specific DNA demethylation (Hackett
et al., 2013), we were interested in examining expression of Tet
genes at a single-cell level in Oct4-GFP+ PGCs at e9.25,
e10.25, and e11.5 (Figures 2A–2D) as well as iPGCs sorted at
day 6 of EB differentiation (Figure 2E). Quantitative RT-PCR
and RNA sequencing have been used to evaluate Tet gene
expression in Oct4-GFP+ PGCs (Hajkova et al., 2010; Yamagu-
chi et al., 2012; Hackett et al., 2013); however, the heterogeneity
between PGCs in sequential developmental ages has not been
well defined. Single-cell analysis revealed that Tet1 is expressed
as early as e9.25, and it was detected in every Dppa3+ PGC
examined to e11.5. In contrast, Tet2 was heterogeneously ex-
pressed at e9.25 and e10.25 (51% and 57% of cells, respec-
tively). At e11.5, the number of Tet2+ PGCs increased substan-
tially to be expressed in almost every Dppa3+ PGC along with
Tet1. Unlike Tet1 and Tet2, Tet3 was expressed in rare Dppa3+
PGCs at e11.5. The cytidine deaminase Aid was negative, sug-
gesting that Aid does not act during this period. Comparably,
by analyzing iPGCs, we discovered that 40 of 40 iPGCs ex-
pressed Tet1 and that almost every single iPGC (39 of 40) also
expressed Tet2 (Figure 2E). Similar to PGCs from the embryo,
we did not find Aid expression in iPGCs, and Tet3 was rarely ex-
pressed (Figure 2E).
Given the expression of at least one or two Tet genes in PGCs,
we analyzed 5hmC by immunostaining (Figures 2F and 2G). We
used the commercially available 5hmC antibody that was
previously confirmed as specifically recognizing 5hmC and not
cytosine or 5mC (Iqbal et al., 2011). To confirm specificity, we
transiently transfected 293T cells with a plasmid encoding the
Tet1 catalytic domain, and a 5hmC-specific signal was only
found in transfected cells (Figure S2A). Next, using this antibody,
we show that 5hmC is present in e10.5 SSEA1+ PGCs (arrowheads) at levels similar to somatic cells (Figure 2F). The expres-
sion of 5hmC was mostly uniform through the PGC nucleus.
However, by e13.5, 5hmC exhibits a characteristic punctate
pattern that overlaps with DAPI+ pericentromeric heterochro-
matin (Figure S2B). Immunohistochemistry of sorted iPGCs
and control SSEA1+ undifferentiated V6.5 ESCs revealed 5hmC
enrichment in both cell types (Figure 2G) (Ficz et al., 2011).
To quantify global levels of 5hmC and 5mC, we used
combined liquid chromatography electro-spray ionization
tandem mass spectrometry with multiple-reaction monitoring
(LC-ESI-MS/MS-MRM) (Figures 2H and 2I). With the use of this
technique, 5.1%of total cytosines in V6.5 ESCsweremethylated
(Figure 2H) in a manner consistent with our previous report (Le
et al., 2011). Next, we found that the levels of 5mC in iPGCs
were significantly reduced to an average of 2.5%, whereas
5mC levels in somatic cells from the same EB were 4.9%.
Furthermore, V6.5 ESCs and iPGCs had a similar 5hmC to
5mC ratio wherein 5hmC is approximately 50-fold lower in abun-
dance than 5mC (Figure 2I). In contrast, analysis of somatic cells
from the EB at day 6 revealed a significant reduction in 5hmC
relative to ESCs, as previously reported (Koh et al., 2011; Tahi-
liani et al., 2009). Altogether, the differentiation of iPGCs from
ESCs is not associated with a significant reduction in 5hmC in
comparison to somatic cells, and this suggests that iPGCs
uniquely regulate 5hmC modification during differentiation.
Tet1 and Tet2 Do Not Regulate Genome-Wide
Demethylation in iPGCs
Given that 5hmC is found on less than 1% of cytosines in
undifferentiated ESCs and iPGCs and that Tet1 and Tet2 are
coexpressed, we considered two alternate hypotheses for
the role of Tet1 and Tet2 in phase 1 genome-wide DNA demethy-
lation. First, we could hypothesize that 5mC oxidation by Tet1
and Tet2 is required for genome-wide DNA demethylation
in iPGCs and that this is initiated extensively in immature
PGCs during EB formation. Therefore, the small measureable
amounts of 5hmC in iPGCs at day 6 would underestimate the
total 5mC to 5hmC conversion that occurred. A second hypo-
thesis could be that 5hmC plays no role in phase 1 DNA deme-
thylation in iPGCs.
To address these possibilities, we designed an experiment to
generate iPGCs from Tet2/ ESCs transduced with a lentivirally
(LV)-delivered small hairpin RNA (shRNA) against Tet1 (shTet1
LV). We used this approach because iPGCs (and many endoge-
nous PGCs) coexpress Tet1 and Tet2 (Figure 2E), and the deple-
tion of Tet1 and Tet2 alone in ESCs results in only mild to
moderate changes in 5hmC (Koh et al., 2011). We found no
statistically significant difference in the percentage of iPGCs
differentiated from Tet2/ ESCs transduced with a control LV
(Tet2/; control LV) relative to Tet2/ ESCs transduced with
the Tet1 shRNA LV (Tet2/; shTet1 LV) (Figure 3A). To deter-
mine knockdown in sorted iPGCs, we used fluorescence-acti-
vated cell sorting (FACS) to isolate iPGCs and examined Tet
gene expression by real-time PCR (Figure 3B). As a positive
control for Tet2, we sorted iPGCs differentiated from V6.5
ESCs transduced with control LV (WT; control LV). Tet1 RNA
was successfully depleted up to 80% with shTet1 LV in iPGCs
(Figure 3B). Tet2 was undetectable in Tet2/ ESCs, and Tet3
levels were very low relative to Tet1 and were unchanged inCell Stem Cell 12, 470–478, April 4, 2013 ª2013 Elsevier Inc. 473
Figure 2. Tet1, Tet2, and 5-Hydroxymethylcytosine Are Present in PGCs and iPGCs
(A–C) FACS plots of GFP+ PGCs (green) sorted from the mouse embryo at the indicated time points.
(D and E) Single-cell analysis of e9.25, e10.25, and e11.5 GFP+ PGCs (D) and iPGCs (E) for Tet1, Tet2, Tet3, and Aid.
(F) Immunofluorescence of e10.5 PGCs for SSEA1 (red) and 5hmC (green).
(G) Immunohistochemistry for 5hmC in sorted day 6 iPGCs and undifferentiated ESCs. Control involves omitting the primary antibody.
(H and I) LC-ESI-MS/MS-MRM analysis of ESCs, iPGCs, and somatic EB cells for 5mC (H) and 5hmC (I) content. Shown are mean ± SD (n = 3). *, p < 0.05.
See also Figures S1 and S2.
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(Figures 3B and 3C). Therefore, modulating Tet gene expression
in iPGCs does not result in the compensatory expression of other
Tet genes, similar to what was reported in undifferentiated ESCs
(Dawlaty et al., 2011; Koh et al., 2011). We also analyzed the
PGC-expressed genes Blimp1 (a determinant of PGC fate),
Dppa3, Prdm14 (a determinant of PGC fate), and Dnd1 and474 Cell Stem Cell 12, 470–478, April 4, 2013 ª2013 Elsevier Inc.found that the manipulation of Tet1 and Tet2 had no significant
effect on the expression of these genes relative to control genes
(Figure 3D).
Finally, we asked whether Tet1 and Tet2 regulate genome-
wide DNA demethylation with iPGC differentiation. If we accept
the hypothesis that Tet1 and/or Tet2 are required for regulating
genome-wide DNA demethylation, we would anticipate that
Figure 3. Tet1 and Tet2 Do Not Regulate Phase 1 Global DNA Demethylation in iPGCs
(A) The yield of iPGCdifferentiations in Tet2/ cells transducedwith a control lentivirus (LV) and an LV containing an shRNA against Tet1 (shTet1 LV) (mean ± SEM
of n = 6).
(B–D) The results of real-time PCR (mean ± SEM of n = 3).
(E and F) LC-ESI-MS/MS-MRM measurements for 5hmC (E) and 5mC (F) in iPGCs and somatic cells (mean ± SD of n = 3).
(G) Genome-wide CG methylation levels by BS-seq calculated from paired experiments (mean ± SEM of n = 3).
(H and I) The number of promoters (H) and gene bodies (I) that exhibit a statistically significant (p < 0.05) decrease (negative) or increase (positive) in CG
methylation in Tet2/; shTet1 LV PGCs.
(J and K) Promoters (J) and gene bodies (K) with differential methylation in Tet2/; shTet1 iPGCs (green arrow, increase in methylation; red arrow, decrease in
methylation). NS, not significant; ND, not detected; *, p < 0.05.
See also Figure S2 and Table S2.
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Tet1 and Tet2 DNA Demethylation of PGCscytosine methylation should significantly increase in Tet2/;
shTet1 LV iPGCs in comparison to Tet2/; control LV. To reject
the hypothesis and find that Tet1 and Tet2 have no major role in
genome-wide iPGC demethylation, we would expect that
Tet2/; shTet1 LV iPGCs would have DNA methylation levels
equivalent to wild-type iPGCs (Figure 1C). Using LC-ESI-MS/
MS-MRM, we found that 5hmC was no longer detectable in
Tet2/; shTet1 iPGCs relative to Tet2/; control LV (Fig-
ure 3E). We also found that, at the start of differentiation (day 6
posttransduction), the Tet2/; shTet1 LV ESC samples had
undetectable levels of 5hmC and no change in 5mC levels in
comparison to Tet2/; control LV (Figures S2C and S2D).
Finally, analysis of 5mC by mass spectrometry revealed no
increase inmethylation in iPGCswith depleted 5hmC (Figure 3F).
Thus, we conclude that Tet1 and Tet2 do not regulate global DNA
demethylation.
Using an alternate approach, whole genome BS-seq in biolog-
ical triplicate, we identified 6,866,888 CG dinucleotides that
were represented in all six libraries, and, in agreement with the
LC-ESI-MS/MS-MRM assay, we show no significant change in
the percentage of CG methylation between Tet2/; shTet1 LV
iPGCs in comparison to Tet2/; control LV iPGCs (Figure 3G).
Combined, our data reject the first hypothesis that Tet1 and
Tet2 regulate genome-wide DNA demethylation during iPGC
differentiation. However, the BS-seq results reveal a small
(4%) increase in methylation in the Tet1 and Tet2 mutant
iPGCs, which suggests locus-specific effects. Indeed, we found
that knockdown of Tet1 in a Tet2/ background had a local
effect on promoter and gene body methylation in iPGCs when
compared to Tet2/ iPGCs transduced with a control LV (Table
S2). Importantly, the most significant directional change
observed was CG hypermethylation in Tet2/; shTet1 LV iPGCs
in comparison to Tet2/; control LV reference iPGCs (Figures
3H and 3I). Some notable hypermethylated promoters included
the genome defense genes Tudor domain containing protein 5
(Tdrd5) and Piwi-like 4 (Piwil4), which are required to repress
transposons later in germ cell development, and Tdrd7, Spag8,
and Pramel1, which are expressed in adult testis (Figure 3J).
Curiously, gene body hypermethylation was discovered on the
germ cell-expressed genes Nanos3, Blimp1, and Dppa2 and
the imprinted genes Peg3 and Snrpn (Figure 3K). However, the
increase in gene bodymethylation atBlimp1 did not alter expres-
sion (Figure 3D). We noted that olfactory receptor (Olfr) RNA and
microRNAs (miRNAs) were highly represented in both promoter
and gene body classifications, and shown here are an Olfr
(Olfr1226) and a miRNA (mir133b) that exhibited hypomethyla-
tion in the Tet1- and Tet2-depleted iPGCs (Figures 3J and 3K).
Altogether, this leads to a model where phase 1 PGC demethy-
lation involving the bulk removal of DNA methylation is Tet1 and
Tet2 independent.
DISCUSSION
Our genome-wide analysis of cytosine methylation with the use
of BS-seq of iPGCs revealed a statistically significant and repro-
ducible genome-wide depletion of cytosine methylation similar
to what was recently reported by Seisenberger et al., 2012.
Specifically, the iPGC model reported here captures the reorga-
nization of cytosine methylation at meiotic CGIs relative to undif-476 Cell Stem Cell 12, 470–478, April 4, 2013 ª2013 Elsevier Inc.ferentiated ESCs and represents a heterogeneous population of
PGCs undergoing global phase 1 DNA demethylation and the
initiation of some locus-specific, Tet-dependent DNA demethy-
lation in phase 2. Although Tet1 and Tet2 were recently reported
to regulate locus-specific demethylation in PGCs (Yamaguchi
et al., 2012; Hackett et al., 2013), it was unknown whether the
initial global depletion of DNA methylation required a 5hmC
intermediate. Here, we show that Tet1, Tet2, and 5hmC are
dispensable for the initial global depletion of 5mC from the
PGC genome. Instead, Tet depletion induces promoter and
gene body hypermethylation that is consistent with 5hmC having
a locus-specific role in DNA demethylation in PGCs (Hackett
et al., 2013).
Our genome-wide analysis reveals approximately 1,000
promoters and gene bodies that are differentially methylated in
Tet1and Tet 2 mutant iPGCs, and the vast majority exhibit signif-
icant hypermethylation. Our data set revealed that Dazl, Sycp3,
and Mael promoter methylation levels were all increased in the
Tet1 and Tet2 mutants, as previously reported (Yamaguchi
et al., 2012; Hackett et al., 2013). However, these changes did
not reach statistical significance in our study, perhaps because
the iPGCs here are younger than e10.5. One interesting observa-
tion was the discovery of important Tet-regulated germ cell-
expressed genes, including Tdrd5, Piwil4 (also called Miwi2),
and Tdrd7 that function in the male germline after e13.5 (Carmell
et al., 2007; Tanaka et al., 2011; Yabuta et al., 2011). This
suggests that 5hmC may prepare the germline epigenome for
future functional events unique to this lineage.
If 5mC oxidation and deamination (Popp et al., 2010) are not
responsible for driving genome-wide depletion in DNA demethy-
lation in PGCs, what could be the mechanism? One possibility is
that global demethylation is linked to abnormalities in replica-
tion-coupled methylation inheritance prior to e9.5. This could
be caused by mislocalization, inactivation, or repression of
DNA methyltransferase 1 (Dnmt1) (Lei et al., 1996) or its cofactor
Uhrf1 during DNA synthesis (Bostick et al., 2007). Hairpin BS-seq
(Laird et al., 2004), which detectsmethylation on complementary
strands of DNA, is one way to address this in the ESC to iPGC
model.
In conclusion, we propose that the differentiation of iPGCs
represents a heterogeneous population of immature PGCs in
the process of undergoing global genome-wide depletion of
methylation during phase 1 and the beginning of Tet-dependent
demethylation in phase 2. Our study demonstrates that Tet1
and Tet2 do not regulate initial genome-wide depletion of 5mC
(Figure 1A) and instead clarifies the model to demonstrate that
Tet1 and Tet2 function to regulate locus-specific methylation
during PGC development.EXPERIMENTAL PROCEDURES
Embryonic Stem Cell Culture and iPGC Differentiation
Mouse ESC maintenance, differentiation, and isolation of iPGCs were per-
formed as previously described (Vincent et al., 2011). For the Tet studies, lenti-
viruses were modified from Ambartsumyan et al., 2010, to carry shRNA
directed against Tet1 mRNA harboring hygromycin resistance. Cells were
transduced with the indicated VSV-G pseudotyped virus at a multiplicity of
infection of 1 and selected in 200 mg/ml hygromycin on inactivated DR4mouse
embryonic fibroblasts. EB differentiation was performed with hygromycin in
the media for 6 days prior to FACS.
Cell Stem Cell
Tet1 and Tet2 DNA Demethylation of PGCsMouse Studies
Oct4-GFP+ embryos were used to isolate PGCs by FACS, as previously
described (Vincent et al., 2011). All research protocols were approved by the
Animal Care and Use Committee at UCLA.
Single-Cell PCR
Single-cell analysis was performed with the use of the Fluidigm BioMark
microfluidics PCR system, as previously described, and involved an 18 cycle
Specific Target Amplification reaction (Vincent et al., 2011). Heatmaps of Ct
values were generated with Fluidigm PCR data analysis software.
Whole-Genome Bisulfite Sequencing
BS-seq libraries were prepared as previously described (Feng et al., 2011).
Libraries were all single-end reads containing premethylated illumina adap-
tors. Libraries were sequenced on either a Genome Analyzer II or HiSeq
2000 and the percentmethylation did not change betweenmachines. Mapping
was performed with the use of BS Seeker, and methylation levels for each
cytosine were determined by measuring the ratio of Cs to Cs plus Ts that align
to each genomic cytosine (Chen et al., 2010). Read lengths ranged from 50 to
80 after trimming 20 bases from the 30 end.Multiple readsmapped to the same
location were considered only once. For deep sequencing of libraries mB557
andmB556 (Table S1), only cytosines with coverageR 4 were included for the
downstream analysis (478,482,437 cytosines). This set was used to acquire
chromosome views, metaplots, Shannon entropy, distribution plots, and anal-
ysis of symmetry. To generate a metaplot of genes, the transcription start and
end sites of selected genes were fixed and the upstream, body, and down-
stream regions were binned into windows. For each window, the average
methylation level was calculated. Therefore, a metagene plot summarized
the average methylation level per window and was plotted from the upstream
to downstream direction. Shannon entropy was calculated Pnl mi LogðmiÞ,
wheremi is the methylation levels estimated at the i-th CG site. In the compar-
ison, we took the average of Shannon entropy (i.e., divided by n). To map DMS
CG, sites were selected with the use of the criteria of delta methylation levels
R 30% and subjected to two-way binomial tests. This yielded 11,994,107 CG
sites for analysis with a false discovery rate (FDR) of% 5%. In the scatter plots,
the points show the D methylation level between the two samples versus the
changes of expression (log2microarray 1–log2microarray 2). Distribution plots
of methylation levels were calculated at each cytosine as the ratio of Cs to Cs
plus Ts that align to each genomic cytosine. The methylation levels of all
cytosines with coverage R 43 were plotted as a histogram. To calculate
symmetry, the methylation status of these cytosines is based on an FDR of
1% and a sequencing error of 1% (Lister et al., 2009). As a result, the methyl-
ation status (methylated or not methylated) of all eligible cytosines were deter-
mined by counting the numbers of both methylated (mC+mG), one methylated
and one unmethylated (mC+uG), and both unmethylated (uC+uG) among CpG
pairs in mBS48 andmBS49. For analysis of Tet2/; LV and Tet2/; Tet1shLV
samples, n = 3 libraries were prepared in biological triplicate in samples that
exhibited knockdown of Tet1 that wasR 69% of the Tet2/; control sample.
This analysis yielded 6,866,888 CG dinucleotides that were represented in all
six libraries and used to calculate the percent of CG methylation. We used
t tests to calculate the significance between two groups.
LC-ESI-MS/MS-MRM
DNA was extracted from freshly sorted cell populations by FACS with a Zymo
Quick-gDNA MiniPrep kit, and LC-ESI-MS/MS-MRM was used to determine
the proportional content of 5mC or 5hmC relative to total cytosine levels,
according to Le et al., 2011.
Immunofluorescence
Paraffin-embedded tissue stainingwas performedwith conventional protocols
with some exceptions. For 5mC and 5hmC staining, tissue was first stained for
othermarkers, postfixed, and denatured for 10min in 4 NHCl prior to overnight
incubation with the appropriate antibodies. The following antibodies were
used: Oct4 (Santa Cruz Biotechnology), E-cadherin (BD Biosciences),
SSEA1 (Developmental Studies Hybridoma Bank), 5mC (Aviva Biosciences),
and 5hmC (Active Motif). Fluorescent visualization was performed with the
use of isotype-specific secondary antibodies conjugated to either fluoresceinisothiocyanate or Alexa Fluor 594 (Jackson ImmunoResearch). All images
were acquired on a Zeiss LSM 780 confocal microscope.
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